Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED | N.MMED.WA | N.MMED.WR | N.MMED.WS

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > Squeeze

<< Previous

Bullboard Posts

Next >>

Comment by Superss63on May 26, 2021 12:20am

191 Views

Post# 33265847

RE:RE:Squeeze

Yeah & those 2 million shares bought at the end of that day that made the price pop about 65 cents was just some guys that had a woody for the stock & nothing to do with the covering of shorts. A short squeeze doesn't have to be prolonged, it could be a settling of accounts & that's exactly what that smelled like.

TeddyTenBags wrote: There's no squeeze coming. Not now. Not any time soon. This stock has hardly been shorted, yet people keep posting about this hoping to get people to buy in for some GME type of run, which ain't happening.

Superss63 wrote: Might see a squeeze here.